ATE175353T1 - Verfahren und system zur empfängnisverhütung - Google Patents
Verfahren und system zur empfängnisverhütungInfo
- Publication number
- ATE175353T1 ATE175353T1 AT89912312T AT89912312T ATE175353T1 AT E175353 T1 ATE175353 T1 AT E175353T1 AT 89912312 T AT89912312 T AT 89912312T AT 89912312 T AT89912312 T AT 89912312T AT E175353 T1 ATE175353 T1 AT E175353T1
- Authority
- AT
- Austria
- Prior art keywords
- day
- progestin
- stage
- composition
- follow
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Communication Control (AREA)
- Control Of Steam Boilers And Waste-Gas Boilers (AREA)
- Transplanting Machines (AREA)
- Moving Of Heads (AREA)
- Apparatus For Radiation Diagnosis (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Photoreceptors In Electrophotography (AREA)
- Developing Agents For Electrophotography (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/260,447 US4921843A (en) | 1988-10-20 | 1988-10-20 | Contraception system and method |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE175353T1 true ATE175353T1 (de) | 1999-01-15 |
Family
ID=22989203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT89912312T ATE175353T1 (de) | 1988-10-20 | 1989-10-19 | Verfahren und system zur empfängnisverhütung |
Country Status (15)
Country | Link |
---|---|
US (1) | US4921843A (de) |
EP (1) | EP0397823B1 (de) |
JP (1) | JP3001216B2 (de) |
KR (1) | KR0182283B1 (de) |
AT (1) | ATE175353T1 (de) |
AU (1) | AU620940B2 (de) |
CA (1) | CA2001144C (de) |
DE (1) | DE68928897T2 (de) |
FI (1) | FI103951B (de) |
HU (2) | HUT51899A (de) |
IL (1) | IL92069A0 (de) |
NZ (1) | NZ231091A (de) |
PT (1) | PT92069B (de) |
WO (1) | WO1990004330A1 (de) |
ZA (1) | ZA897977B (de) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5108995A (en) * | 1987-09-24 | 1992-04-28 | Jencap Research Ltd. | Hormone preparation and method |
DE4104385C1 (de) * | 1991-02-09 | 1992-08-13 | Marika Dr.Med. 6509 Framersheim De Ehrlich | |
US6407082B1 (en) * | 1996-09-13 | 2002-06-18 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of a vitamin D compound |
DE4344405C2 (de) * | 1993-12-24 | 1995-12-07 | Marika Dr Med Ehrlich | Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption |
DE4411585A1 (de) * | 1994-03-30 | 1995-10-05 | Schering Ag | Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption |
DE4429374C1 (de) * | 1994-08-12 | 1996-02-01 | Jenapharm Gmbh | Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente |
DE19513662A1 (de) * | 1995-04-08 | 1996-10-10 | Schering Ag | Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption |
DE19540253C2 (de) * | 1995-10-28 | 1998-06-04 | Jenapharm Gmbh | Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene |
US20050032756A1 (en) * | 1995-10-28 | 2005-02-10 | Michael Dittgen | Multistage preparation for contraception based on natural estrogens |
US5747480A (en) * | 1996-05-08 | 1998-05-05 | American Home Products Corporation | Oral contraceptive |
US6479475B1 (en) | 1996-07-26 | 2002-11-12 | Wyeth | Oral contraceptive |
US5888543A (en) * | 1996-07-26 | 1999-03-30 | American Home Products Corporation | Oral contraceptives |
US6451778B1 (en) | 1996-07-26 | 2002-09-17 | Wyeth | Oral contraceptive |
WO1998004267A1 (en) * | 1996-07-26 | 1998-02-05 | American Home Products Corporation | Progestin/estrogen oral contraceptive |
US5858405A (en) * | 1996-07-26 | 1999-01-12 | American Home Products Corporation | Oral contraceptive |
US6034074A (en) | 1996-09-13 | 2000-03-07 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of a Vitamin D compound |
US6511970B1 (en) | 1996-09-13 | 2003-01-28 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium |
US6028064A (en) | 1996-09-13 | 2000-02-22 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of progestin products |
US6765002B2 (en) | 2000-03-21 | 2004-07-20 | Gustavo Rodriguez | Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium |
FR2754179B1 (fr) | 1996-10-08 | 1998-12-24 | Theramex | Nouvelle composition hormononale et son utilisation |
WO2001030355A1 (fr) | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation |
US6251956B1 (en) | 1998-08-20 | 2001-06-26 | Ortho Pharmaceutical Corporation | Combination progestin oral contraceptive regimen |
PT1007052E (pt) * | 1997-08-27 | 2005-01-31 | Ortho Mcneil Pharm Inc | Combinacoes de progestinas de crescimento do endometrico e progestinas de atropia do endometrio com estrogenios, em contracepcao oral |
AU1518900A (en) * | 1998-11-12 | 2000-06-05 | Warner Chilcott Laboratories Ireland Limited | Graduated progestin contraceptive |
US6214815B1 (en) | 1998-12-23 | 2001-04-10 | Ortho-Mcneil Pharmaceuticals, Inc. | Triphasic oral contraceptive |
US7763276B1 (en) * | 1999-02-26 | 2010-07-27 | Shionogi & Co., Ltd. | Chewable soft capsules having improved administration properties and process for producing the same |
US6660726B2 (en) * | 2000-03-10 | 2003-12-09 | Endeavor Pharmaceuticals | Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same |
US7989436B2 (en) | 2003-07-23 | 2011-08-02 | Duramed Pharmaceuticals, Inc. | Estrogenic compounds and pharmaceutical formulations comprising the same |
US6855703B1 (en) | 2000-03-10 | 2005-02-15 | Endeavor Pharmaceuticals | Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds |
US7459445B2 (en) * | 2000-03-10 | 2008-12-02 | Duramed Pharmaceuticals, Inc. | Estrogenic compounds and topical pharmaceutical formulations of the same |
US20040176336A1 (en) * | 2000-03-21 | 2004-09-09 | Rodriguez Gustavo C. | Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium |
US20050113351A1 (en) * | 2000-03-21 | 2005-05-26 | Rodriguez Gustavo C. | Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium |
US20010044431A1 (en) * | 2000-03-21 | 2001-11-22 | Rodriguez Gustavo C. | Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium |
DK1293210T3 (da) * | 2001-05-23 | 2004-03-15 | Pantarhei Bioscience Bv | Midler og fremgangsmåde til hormonal prævention |
EP2305229A1 (de) * | 2001-12-05 | 2011-04-06 | Teva Women's Health, Inc. | Orale Verhütungsmittel zum Verhindern einer Schwangerschaft und Reduzierung von prämenstruellen Symptomen |
JP2004140323A (ja) * | 2002-08-20 | 2004-05-13 | Sharp Corp | 半導体レーザ装置およびその製造方法 |
US6992075B2 (en) * | 2003-04-04 | 2006-01-31 | Barr Laboratories, Inc. | C(14) estrogenic compounds |
WO2004091535A2 (en) * | 2003-04-11 | 2004-10-28 | Barr Laboratories, Inc. | Methods of administering estrogens and progestins |
EP1689411B1 (de) * | 2003-11-14 | 2008-10-08 | Warner Chilcott Company Inc. | Graduierte östrogen-kontrazeptiva |
EP1550447A1 (de) * | 2004-01-02 | 2005-07-06 | Schering Aktiengesellschaft | Menstruationszykluskontrolle und Verbesserung der weiblichen Empfängnisrate |
CN1933873A (zh) * | 2004-03-19 | 2007-03-21 | 沃纳奇尔科特公司 | 延长周期的多相口服避孕方法 |
DE102004019743B4 (de) * | 2004-04-20 | 2008-11-27 | Bayer Schering Pharma Aktiengesellschaft | Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens |
EP1853272A1 (de) * | 2005-02-03 | 2007-11-14 | Duramed Pharmaceuticals, Inc. | Zusammensetzungen aus unkonjugierten östrogenen und anwendungsverfahren dafür |
US7704984B2 (en) * | 2005-04-22 | 2010-04-27 | Warner Chilcott Company, Llc | Extended estrogen dosing contraceptive regimen |
US8153616B2 (en) * | 2005-10-17 | 2012-04-10 | Bayer Pharma Aktiengesellschaft | Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same |
EP1930010A1 (de) * | 2006-10-20 | 2008-06-11 | Bayer Schering Pharma Aktiengesellschaft | Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL6615481A (de) * | 1966-11-02 | 1968-05-03 | ||
US3409721A (en) * | 1967-09-15 | 1968-11-05 | Neomed Lab Inc | Oral dosage system effective to control the reproduction cycle |
US4372951A (en) * | 1979-10-11 | 1983-02-08 | Nichols Vorys | Vaginal delivery for physiologic follicular-luteal steroid treatment |
US4616006A (en) * | 1983-09-26 | 1986-10-07 | Ortho Pharmaceutical Corporation | Triphasic oral contraceptive |
US4628051A (en) * | 1983-09-26 | 1986-12-09 | Ortho Pharmaceutical Corporation | Triphasic oral contraceptive |
US4544554A (en) * | 1983-09-26 | 1985-10-01 | Ortho Pharmaceutical Corporation | Triphasic oral contraceptive |
DE3347125A1 (de) * | 1983-12-22 | 1985-07-11 | Schering AG, 1000 Berlin und 4709 Bergkamen | Mehrstufenkombinationspraeparat und seine verwendung zur oralen kontrazeption |
-
1988
- 1988-10-20 US US07/260,447 patent/US4921843A/en not_active Ceased
-
1989
- 1989-10-19 KR KR1019900701321A patent/KR0182283B1/ko not_active IP Right Cessation
- 1989-10-19 HU HU895364A patent/HUT51899A/hu unknown
- 1989-10-19 EP EP89912312A patent/EP0397823B1/de not_active Expired - Lifetime
- 1989-10-19 AT AT89912312T patent/ATE175353T1/de not_active IP Right Cessation
- 1989-10-19 WO PCT/US1989/004697 patent/WO1990004330A1/en active IP Right Grant
- 1989-10-19 DE DE68928897T patent/DE68928897T2/de not_active Expired - Lifetime
- 1989-10-19 AU AU44970/89A patent/AU620940B2/en not_active Expired
- 1989-10-19 JP JP1511457A patent/JP3001216B2/ja not_active Expired - Lifetime
- 1989-10-20 ZA ZA897977A patent/ZA897977B/xx unknown
- 1989-10-20 CA CA002001144A patent/CA2001144C/en not_active Expired - Lifetime
- 1989-10-20 PT PT92069A patent/PT92069B/pt not_active IP Right Cessation
- 1989-10-20 IL IL92069A patent/IL92069A0/xx not_active IP Right Cessation
- 1989-10-20 NZ NZ231091A patent/NZ231091A/en unknown
-
1990
- 1990-06-20 FI FI903106A patent/FI103951B/fi active IP Right Grant
-
1995
- 1995-06-29 HU HU95P/P00591P patent/HU211931A9/hu unknown
Also Published As
Publication number | Publication date |
---|---|
ZA897977B (en) | 1990-07-25 |
CA2001144C (en) | 1999-07-20 |
PT92069B (pt) | 1995-06-30 |
AU4497089A (en) | 1990-05-14 |
EP0397823A1 (de) | 1990-11-22 |
FI103951B1 (fi) | 1999-10-29 |
AU620940B2 (en) | 1992-02-27 |
KR900701277A (ko) | 1990-12-01 |
NZ231091A (en) | 1995-12-21 |
FI103951B (fi) | 1999-10-29 |
HU211931A9 (en) | 1996-01-29 |
FI903106A0 (fi) | 1990-06-20 |
WO1990004330A1 (en) | 1990-05-03 |
EP0397823A4 (en) | 1991-04-03 |
HUT51899A (en) | 1990-06-28 |
DE68928897D1 (de) | 1999-02-18 |
IL92069A0 (en) | 1990-07-12 |
US4921843A (en) | 1990-05-01 |
JP3001216B2 (ja) | 2000-01-24 |
CA2001144A1 (en) | 1990-04-20 |
EP0397823B1 (de) | 1999-01-07 |
JPH03502932A (ja) | 1991-07-04 |
KR0182283B1 (ko) | 1999-05-01 |
DE68928897T2 (de) | 1999-07-29 |
PT92069A (pt) | 1990-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE175353T1 (de) | Verfahren und system zur empfängnisverhütung | |
DK365887D0 (da) | Kombinationsdoseringsform til hormonbehandling af kvinder i prae-menopausen | |
KR960706344A (ko) | 호르몬 피임 및/또는 여드름 치료 수단 및 방법(means and method for hormonal contraception and/or the treatment of acne) | |
ATE216241T1 (de) | Sehr niedrigdosiertes orales kontrazeptiv mit weniger menstruationsblutungen und verzögerter wirkung | |
ATE239483T1 (de) | Pharmazeutisches kombinationspräparat, kit und methode zur hormonalen kontrazeption | |
KR890700349A (ko) | 피임 및 유방암 억제용 조성물 및 이의 제조방법 | |
CA2188907A1 (en) | Combination compound for contraception based on natural estrogen | |
DE69710896D1 (en) | Progestogen-anti-progestogen therapien | |
RU96119803A (ru) | Комбинированный препарат для контрацепции на базе природных эстрогенов | |
IT1170214B (it) | Composizione farmaceutica per la cura delle arteriopatie periferiche | |
PT94787A (pt) | Processo de preparacao de composicoes farmaceuticas para administracao transdermica de corticosteroides e de compostos com actividade fisiologica semelhante | |
ATE73664T1 (de) | Arzneimittel zur regulierung der hormonellen sekretionen und zur behandlung der weiblichen sterilitaet. | |
TH14144EX (th) | การลดการสูญเสียโลหิตแบบไหลออกที่เกิดจากการใช้โปรเกสทิน |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
EEFA | Change of the company name | ||
EELA | Cancelled due to lapse of time |